tiprankstipranks
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market

Appili Therapeutics Inc Class A (APLIF) Financial Statements

Compare
81 Followers

Appili Therapeutics Inc Class A Financial Overview

Appili Therapeutics Inc Class A's market cap is currently $3.41M. The company's EPS TTM is $-0.023; its P/E ratio is ―; Appili Therapeutics Inc Class A is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total RevenueC$ 827.41KC$ 334.18KC$ 1.39MC$ 0.00C$ 199.11K
Gross ProfitC$ 827.41KC$ 327.91KC$ 1.39MC$ -14.84KC$ 199.11K
Operating IncomeC$ -8.05MC$ -7.91MC$ -24.68MC$ -16.30MC$ -6.13M
EBITDAC$ -2.10MC$ -8.19MC$ -24.31MC$ -14.87MC$ -5.63M
Net IncomeC$ -3.78MC$ -9.24MC$ -25.12MC$ -14.33MC$ -5.42M
Balance Sheet
Cash & Short-Term InvestmentsC$ 94.49KC$ 2.47MC$ 6.66MC$ 16.12MC$ 10.54M
Total AssetsC$ 1.49MC$ 3.13MC$ 8.28MC$ 18.32MC$ 11.17M
Total DebtC$ 8.18MC$ 7.67MC$ 4.98MC$ 1.03MC$ 1.00M
Net DebtC$ 8.09MC$ 5.20MC$ -1.69MC$ -10.03MC$ -9.50M
Total LiabilitiesC$ 12.42MC$ 10.53MC$ 11.55MC$ 5.56MC$ 2.33M
Stockholders' EquityC$ -10.92MC$ -7.40MC$ -3.27MC$ 12.75MC$ 8.85M
Cash Flow
Free Cash FlowC$ -2.49MC$ -10.10MC$ -19.08MC$ -11.46MC$ -4.26M
Operating Cash FlowC$ -2.46MC$ -10.10MC$ -19.08MC$ -11.45MC$ -4.26M
Investing Cash FlowC$ -29.06KC$ -3.17KC$ 5.06MC$ -4.99MC$ -1.14K
Financing Cash FlowC$ 122.05KC$ 5.91MC$ 9.56MC$ 17.02MC$ 9.36M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Appili Therapeutics Inc Class A Debt to Assets

Appili Therapeutics Inc Class A Cash Flow

Appili Therapeutics Inc Class A Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis